R&D News | pharmaphorum

News

A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.

News

Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.

News

Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy works better than Eli Lilly's fast-growing rival Zepbound.

News

The race to market is on with Mineralys, as AstraZeneca showcases data for aldosterone synthase inhibitor baxdrostat in uncontrolled hypertension.

News

The current director of the CDC is challenging her dismissal, but that has not stopped the White House from appointing a replacement.

News

Replicate will receive up to $550m from Novo Nordisk in an alliance that aims to deliver a new generation of drugs for obesity and diabetes.